Physician
Gherardi, Olivier
Gherardi, Olivier was paid $55K by Medicaid between Jan 2018 and Aug 2022, across 5 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 61% of everything it billed.
33Billing provider infoGHERARDI, OLIVIER
WARWICK, RI 02889
WARWICK, RI 02889
33aNPI1558324970assigned 04/07/2006
33bProvider typeFamily Medicine Physician
28Total paid$55K
24GClaims508
24DCodes billed5
24AFirst – last monthJan 2018 – Aug 2022
Compared with peers
Next to other Family Medicine Physician providers in Rhode Island
Rank by total paid#83 of 220
Median peer was paid$33K
This provider vs. median1.6×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 323 | $39K | |
| 2019 | 159 | $13K | |
| 2022 | 26 | $3K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 61% | 317 | 305 | $33K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 32% | 150 | 150 | $17K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 4.2% | 13 | 13 | $2K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 2.3% | 15 | 15 | $1K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 1.1% | 13 | 13 | $576.55 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.